BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31375988)

  • 1. Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction.
    Pedersen A; Stanne TM; Nilsson S; Klasson S; Rosengren L; Holmegaard L; Jood K; Blennow K; Zetterberg H; Jern C
    J Neurol; 2019 Nov; 266(11):2796-2806. PubMed ID: 31375988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke.
    Uphaus T; Bittner S; Gröschel S; Steffen F; Muthuraman M; Wasser K; Weber-Krüger M; Zipp F; Wachter R; Gröschel K
    Stroke; 2019 Nov; 50(11):3077-3084. PubMed ID: 31537188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke.
    Onatsu J; Vanninen R; Jäkälä P; Mustonen P; Pulkki K; Korhonen M; Hedman M; Zetterberg H; Blennow K; Höglund K; Herukka SK; Taina M
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2242-2249. PubMed ID: 31151840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Neurofilament Light Chain Levels Are Associated with Clinical Characteristics and Outcome in Patients with Cervical Artery Dissection.
    Traenka C; Disanto G; Seiffge DJ; Gensicke H; Hert L; Grond-Ginsbach C; Peters N; Regeniter A; Kloss M; De Marchis GM; Bonati LH; Lyrer PA; Kuhle J; Engelter ST
    Cerebrovasc Dis; 2015; 40(5-6):222-7. PubMed ID: 26418549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neurofilament light chain in patients with acute cerebrovascular events.
    De Marchis GM; Katan M; Barro C; Fladt J; Traenka C; Seiffge DJ; Hert L; Gensicke H; Disanto G; Sutter R; Peters N; Sarikaya H; Goeggel-Simonetti B; El-Koussy M; Engelter S; Lyrer PA; Christ-Crain M; Arnold M; Kuhle J; Bonati LH
    Eur J Neurol; 2018 Mar; 25(3):562-568. PubMed ID: 29281157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Neurofilament Light Chain as a Predictive Biomarker for Ischemic Stroke Outcome: A Systematic Review and Meta-analysis.
    Liu D; Chen J; Wang X; Xin J; Cao R; Liu Z
    J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104813. PubMed ID: 32305278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Neurofilament Light Predicts Severity and Prognosis in Patients with Ischemic Stroke.
    Wang P; Fan J; Yuan L; Nan Y; Nan S
    Neurotox Res; 2020 Apr; 37(4):987-995. PubMed ID: 31898161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke.
    Tiedt S; Duering M; Barro C; Kaya AG; Boeck J; Bode FJ; Klein M; Dorn F; Gesierich B; Kellert L; Ertl-Wagner B; Goertler MW; Petzold GC; Kuhle J; Wollenweber FA; Peters N; Dichgans M
    Neurology; 2018 Oct; 91(14):e1338-e1347. PubMed ID: 30217937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum biomarker neurofilament light concentration with post-stroke depression: A preliminary study.
    Zhao H; Mo M; Miao C; Li L; Yang H; Liu Y; Yang G
    Gen Hosp Psychiatry; 2020; 64():17-25. PubMed ID: 32078857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
    Disanto G; Barro C; Benkert P; Naegelin Y; Schädelin S; Giardiello A; Zecca C; Blennow K; Zetterberg H; Leppert D; Kappos L; Gobbi C; Kuhle J;
    Ann Neurol; 2017 Jun; 81(6):857-870. PubMed ID: 28512753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association of Serum Neurofilament Light Chain and Acute Ischaemic Stroke Is Influenced by Effective Revascularization.
    Zhou FY; Chen DW; Li HY; Zhu C; Shen YY; Peng ZY; Li L; Bu XL; Zeng GH; Zhang M; Wang YJ; Jin WS
    Dis Markers; 2022; 2022():5236080. PubMed ID: 35557872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neurofilament light chain: a predictive marker for outcomes following mild-to-moderate ischemic stroke.
    Xu C; Yi T; Qing T; Jiang Y; Yi X; Xu J; Ma J
    Front Neurol; 2024; 15():1398826. PubMed ID: 38841696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome.
    Altmann P; De Simoni D; Kaider A; Ludwig B; Rath J; Leutmezer F; Zimprich F; Hoeftberger R; Lunn MP; Heslegrave A; Berger T; Zetterberg H; Rommer PS
    J Neuroinflammation; 2020 Mar; 17(1):86. PubMed ID: 32183837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke.
    Pujol-Calderón F; Portelius E; Zetterberg H; Blennow K; Rosengren LE; Höglund K
    Neurosci Lett; 2019 Apr; 698():58-63. PubMed ID: 30599262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neurofilament light chain levels are associated with early neurological deterioration in minor ischemic stroke.
    Li J; Zhang P; Zhu Y; Duan Y; Liu S; Fan J; Chen H; Wang C; Yi X
    Front Neurol; 2023; 14():1096358. PubMed ID: 36970517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
    Siller N; Kuhle J; Muthuraman M; Barro C; Uphaus T; Groppa S; Kappos L; Zipp F; Bittner S
    Mult Scler; 2019 Apr; 25(5):678-686. PubMed ID: 29542376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis.
    Bjornevik K; Munger KL; Cortese M; Barro C; Healy BC; Niebuhr DW; Scher AI; Kuhle J; Ascherio A
    JAMA Neurol; 2020 Jan; 77(1):58-64. PubMed ID: 31515562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke.
    Stanne TM; Åberg ND; Nilsson S; Jood K; Blomstrand C; Andreasson U; Blennow K; Zetterberg H; Isgaard J; Svensson J; Jern C
    Stroke; 2016 Jul; 47(7):1943-5. PubMed ID: 27301948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD.
    Watanabe M; Nakamura Y; Michalak Z; Isobe N; Barro C; Leppert D; Matsushita T; Hayashi F; Yamasaki R; Kuhle J; Kira JI
    Neurology; 2019 Sep; 93(13):e1299-e1311. PubMed ID: 31471502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes.
    Wong YYM; Bruijstens AL; Barro C; Michalak Z; Melief MJ; Wierenga AF; van Pelt ED; Neuteboom RF; Kuhle J; Hintzen RQ
    Neurology; 2019 Sep; 93(10):e968-e974. PubMed ID: 31383792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.